196 related articles for article (PubMed ID: 12110607)
21. Drug specificity and intestinal membrane localization of human organic cation transporters (OCT).
Müller J; Lips KS; Metzner L; Neubert RH; Koepsell H; Brandsch M
Biochem Pharmacol; 2005 Dec; 70(12):1851-60. PubMed ID: 16263091
[TBL] [Abstract][Full Text] [Related]
22. Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver.
Nies AT; Koepsell H; Winter S; Burk O; Klein K; Kerb R; Zanger UM; Keppler D; Schwab M; Schaeffeler E
Hepatology; 2009 Oct; 50(4):1227-40. PubMed ID: 19591196
[TBL] [Abstract][Full Text] [Related]
23. Transport of dicationic drugs pentamidine and furamidine by human organic cation transporters.
Ming X; Ju W; Wu H; Tidwell RR; Hall JE; Thakker DR
Drug Metab Dispos; 2009 Feb; 37(2):424-30. PubMed ID: 18971316
[TBL] [Abstract][Full Text] [Related]
24. Membrane transporters in drug development.
; Giacomini KM; Huang SM; Tweedie DJ; Benet LZ; Brouwer KL; Chu X; Dahlin A; Evers R; Fischer V; Hillgren KM; Hoffmaster KA; Ishikawa T; Keppler D; Kim RB; Lee CA; Niemi M; Polli JW; Sugiyama Y; Swaan PW; Ware JA; Wright SH; Yee SW; Zamek-Gliszczynski MJ; Zhang L
Nat Rev Drug Discov; 2010 Mar; 9(3):215-36. PubMed ID: 20190787
[TBL] [Abstract][Full Text] [Related]
25. Characterization of human organic cation transporter 1 (OCT1/SLC22A1)- and OCT2 (SLC22A2)-mediated transport of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)- 4,9-dihydro-1H-naphtho[2,3-d]imidazolium bromide (YM155 monobromide), a novel small molecule survivin suppressant.
Minematsu T; Iwai M; Umehara K; Usui T; Kamimura H
Drug Metab Dispos; 2010 Jan; 38(1):1-4. PubMed ID: 19833842
[TBL] [Abstract][Full Text] [Related]
26. Transport of lamivudine [(-)-beta-L-2',3'-dideoxy-3'-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3.
Minuesa G; Volk C; Molina-Arcas M; Gorboulev V; Erkizia I; Arndt P; Clotet B; Pastor-Anglada M; Koepsell H; Martinez-Picado J
J Pharmacol Exp Ther; 2009 Apr; 329(1):252-61. PubMed ID: 19141712
[TBL] [Abstract][Full Text] [Related]
27. Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2).
Zolk O; Solbach TF; König J; Fromm MF
Naunyn Schmiedebergs Arch Pharmacol; 2009 Apr; 379(4):337-48. PubMed ID: 19002438
[TBL] [Abstract][Full Text] [Related]
28. Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.
Bachmakov I; Glaeser H; Fromm MF; König J
Diabetes; 2008 Jun; 57(6):1463-9. PubMed ID: 18314419
[TBL] [Abstract][Full Text] [Related]
29. Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain.
Amphoux A; Vialou V; Drescher E; Brüss M; Mannoury La Cour C; Rochat C; Millan MJ; Giros B; Bönisch H; Gautron S
Neuropharmacology; 2006 Jun; 50(8):941-52. PubMed ID: 16581093
[TBL] [Abstract][Full Text] [Related]
30. Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3).
Bourdet DL; Pritchard JB; Thakker DR
J Pharmacol Exp Ther; 2005 Dec; 315(3):1288-97. PubMed ID: 16141367
[TBL] [Abstract][Full Text] [Related]
31. Comparative analysis of novel decynium-22 analogs to inhibit transport by the low-affinity, high-capacity monoamine transporters, organic cation transporters 2 and 3, and plasma membrane monoamine transporter.
Fraser-Spears R; Krause-Heuer AM; Basiouny M; Mayer FP; Manishimwe R; Wyatt NA; Dobrowolski JC; Roberts MP; Greguric I; Kumar N; Koek W; Sitte HH; Callaghan PD; Fraser BH; Daws LC
Eur J Pharmacol; 2019 Jan; 842():351-364. PubMed ID: 30473490
[TBL] [Abstract][Full Text] [Related]
32. Functional analysis of organic cation transporter 3 expressed in human placenta.
Sata R; Ohtani H; Tsujimoto M; Murakami H; Koyabu N; Nakamura T; Uchiumi T; Kuwano M; Nagata H; Tsukimori K; Nakano H; Sawada Y
J Pharmacol Exp Ther; 2005 Nov; 315(2):888-95. PubMed ID: 16081676
[TBL] [Abstract][Full Text] [Related]
33. Organic cation transporters in psychiatric and substance use disorders.
Honan LE; Fraser-Spears R; Daws LC
Pharmacol Ther; 2024 Jan; 253():108574. PubMed ID: 38072333
[TBL] [Abstract][Full Text] [Related]
34. The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy.
Puris E; Fricker G; Gynther M
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839686
[TBL] [Abstract][Full Text] [Related]
35. Investigations with Drugs and Pesticides Revealed New Species- and Substrate-Dependent Inhibition by Elacridar and Imazalil in
Kuehne A; Floerl S; Hagos Y
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555439
[TBL] [Abstract][Full Text] [Related]
36. Structural basis of organic cation transporter-3 inhibition.
Khanppnavar B; Maier J; Herborg F; Gradisch R; Lazzarin E; Luethi D; Yang JW; Qi C; Holy M; Jäntsch K; Kudlacek O; Schicker K; Werge T; Gether U; Stockner T; Korkhov VM; Sitte HH
Nat Commun; 2022 Nov; 13(1):6714. PubMed ID: 36344565
[TBL] [Abstract][Full Text] [Related]
37. High Affinity Decynium-22 Binding to Brain Membrane Homogenates and Reduced Dorsal Camouflaging after Acute Exposure to it in Zebrafish.
Gould GG; Barba-Escobedo PA; Horton RE; Daws LC
Front Pharmacol; 2022; 13():841423. PubMed ID: 35754508
[TBL] [Abstract][Full Text] [Related]
38. Organic Cation Transporter-Mediated Accumulation of Quinolinium Salts in the LV Myocardium of Rodents.
Grievink H; Shamni O; Krajewski S; Steczek Ł; Gründemann D; Mishani E; Abourbeh G
Mol Imaging Biol; 2022 Oct; 24(5):1-9. PubMed ID: 35441946
[TBL] [Abstract][Full Text] [Related]
39. MPP
Mocking TAM; Sijben HJ; Vermeulen YW; IJzerman AP; Heitman LH
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163125
[TBL] [Abstract][Full Text] [Related]
40. Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter.
Angenoorth TJF; Stankovic S; Niello M; Holy M; Brandt SD; Sitte HH; Maier J
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
